Literature DB >> 17982424

Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters.

Susan L Semple-Rowland1, Kristofer S Eccles, Elizabeth J Humberstone.   

Abstract

PURPOSE: There is increasing interest in developing viral vectors capable of reliably delivering multiple therapeutic genes to targeted cell populations. Currently, bicistronic vectors carrying two transgenes linked by an internal ribosomal entry site (IRES) are the most commonly employed vectors to accomplish this goal. We and others have found that the protein encoded downstream of the IRES in these vectors is not reliably expressed. The purpose of this study was to determine if replacement of the IRES in our self-inactivating, insulated, lentiviral vectors with a second, independent, cell-specific promoter would produce a vector that reliably expressed two proteins in targeted retinal cells in vivo.
METHODS: Five dual promoter lentiviral vectors were constructed using our self-inactivating (SIN), insulated, lentiviral backbone. Each vector carried two independent transgenes encoding a fluorescent protein (GFP or tdTomato) whose expression was driven by three photoreceptor promoters (interphotoreceptor retinoid binding protein-IRPB1783; guanylate cyclase activating protein 1-GCAP292; rhodopsin-mOP500) and one ubiquitously expressed promoter (elongation factor 1alpha-EF1alpha). Constructs were packaged and injected into the optic vesicles of developing chicken embryos. The day before hatching, the retinas were removed and examined as whole mount tissues and as frozen sections using fluorescent microscopy.
RESULTS: In our first experiment, we characterized the expression of the three photoreceptor promoters in chicken retina. The activities of GCAP292 and IRBP1783 were restricted to cone cells. GCAP292 was also active in a small sub-group of inner nuclear cells. The activity of mOP500 was restricted to rod cells. In our second experiment, we characterized the activity of three dual promoter vectors: GCAP292-GFP-IRBP1783-tdTomato, IRBP-tdTomato-GCAP292-GFP, and IRBP1783-tdTomato-mOP500-GFP. All three vectors produced easily detectable levels of GFP and tdTomato in transduced retinas, a result that prompted further analyses of the expression characteristics of these vectors. In retinas treated with either of the GCAP292/IRBP1783 dual promoter vectors, GFP and tdTomato were only detected in cone cells. No GFP was detected in the inner retina. In retinas treated with IRBP1783-tdTomato-mOP500-GFP, tdTomato was detected only in cone cells and GFP was detected only in rod cells, a result indicating that these promoters retained their intrinsic expression specificities in this dual promoter vector. In our final experiment, the ubiquitously expressed EF1alpha promoter was paired with either GCAP292 or mOP500 creating EF1alpha-tdTomato-GCAP292-GFP and EF1alpha-tdTomato-mOP-GFP. In retinas treated with EF1alpha-tdTomato-GCAP292-GFP, GFP was only detected in cone cells. In retinas treated with EF1alpha-tdTomato-mOP500-GFP, GFP was detected in rod cells and in several cells within the inner retina.
CONCLUSIONS: The results of this study show that it is possible to construct dual promoter lentiviral vectors that reliably express two proteins in a cell-specific manner. Among the dual promoter vectors created for this study, we have identified two vectors that specifically target expression of both transgenes to cone cells and one vector that specifically targets expression of one transgene to cone cells and the other transgene to rod cells. The ability to create one lentiviral vector that is capable of targeting expression of multiple genes to single or multiple cells in vivo should prove very useful in the development and delivery of complex, combination therapies to diseased tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982424

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  12 in total

1.  Reduction of Dicer impairs Schwann cell differentiation and myelination.

Authors:  Jonathan D Verrier; Susan Semple-Rowland; Irina Madorsky; Joseph E Papin; Lucia Notterpek
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

2.  Alternative splicing of neuroligin and its protein distribution in the outer plexiform layer of the chicken retina.

Authors:  Karl J Wahlin; Laszlo Hackler; Ruben Adler; Donald J Zack
Journal:  J Comp Neurol       Date:  2010-12-15       Impact factor: 3.215

3.  PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus.

Authors:  Travis C Jackson; Jonathan D Verrier; Susan Semple-Rowland; Ashok Kumar; Thomas C Foster
Journal:  J Neurochem       Date:  2010-09-28       Impact factor: 5.372

Review 4.  Lentiviral vectors in gene therapy: their current status and future potential.

Authors:  David Escors; Karine Breckpot
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-02-09       Impact factor: 4.291

5.  Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells.

Authors:  Susan L Semple-Rowland; William E Coggin; Mero Geesey; Kristofer S Eccles; Leah Abraham; Krunal Pachigar; Rachel Ludlow; Shahrokh C Khani; W Clay Smith
Journal:  Mol Vis       Date:  2010-05-27       Impact factor: 2.367

6.  Role of estrogen receptor α and β in preserving hippocampal function during aging.

Authors:  Xiaoxia Han; Kristina K Aenlle; Linda A Bean; Asha Rani; Susan L Semple-Rowland; Ashok Kumar; Thomas C Foster
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

7.  Use of lentiviral vectors to deliver and express bicistronic transgenes in developing chicken embryos.

Authors:  Susan L Semple-Rowland; Jonathan Berry
Journal:  Methods       Date:  2013-06-28       Impact factor: 3.608

Review 8.  Rediscovering the chick embryo as a model to study retinal development.

Authors:  M Natalia Vergara; M Valeria Canto-Soler
Journal:  Neural Dev       Date:  2012-06-27       Impact factor: 3.842

9.  A tunable dual-promoter integrator for targeting of cancer cells.

Authors:  Lior Nissim; Roy H Bar-Ziv
Journal:  Mol Syst Biol       Date:  2010-12-21       Impact factor: 11.429

Review 10.  Vector platforms for gene therapy of inherited retinopathies.

Authors:  Ivana Trapani; Agostina Puppo; Alberto Auricchio
Journal:  Prog Retin Eye Res       Date:  2014-08-12       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.